S. 2121
Referred to CommitteeSUPPORT for Patients and Communities Reauthorization Act of 2025
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
6/18/2025 • Senate
Summary
SUPPORT for Patients and Communities Reauthorization Act of 2025
This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health.
For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to
• addressing substance use disorders with respect to pregnant and postpartum women,
• prevention and recovery from substance use disorders for youth,
• housing for individuals in recovery from substance use disorders,
• community organizations facilitating recovery from substance use disorders,
• loan repayment for certain health care providers treating substance use disorders,
• prevention of overdoses of controlled substances,
• treatment of children experiencing psychological trauma, and
• mental and behavioral health education and training for medical and allied health students.
Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.
Additionally, the bill establishes new requirements for HHS, including requirements relating to
• protecting the National Suicide Prevention Lifeline program from cybersecurity threats,
• establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and
• reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.
Introduced in Senate • 6/18/2025
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (9)
Party Breakdown
Sponsor
Cosponsors (8)
Bill Journey
Originated in the Senate
Introduced
June 18, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Related Bills (9)
H.R. 4079
Safer Response Act of 2025
H.R. 912
9–8–8 Lifeline Cybersecurity Responsibility Act
H.R. 1768
Lower Costs for Everyday Americans Act
S. 946
MATE Improvement Act
S. 891
Bipartisan Health Care Act
S. 500
CAREER Act of 2025
S. 2532
Safe Response Act
H.R. 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025
S. 3006
Youth Prevention and Recovery Reauthorization Act of 2025